zurig 80 film coated tablet
cadila pharmaceuticals limited, india - febuxoastat - film coated tablet - 80
zurig 80 film coated tablet
zydus lifesciences limited, india - febuxostat - film coated tablet - 80
zurig 40 tablet, coated
cadila pharmaceuticals limited, india - febuxostat - tablet, coated - 40
zurig 40 tablet, coated
zydus lifesciences limited, india - febuxostat - tablet, coated - 40
tepadina powder for solution
adienne sa - thiotepa - powder for solution - 15mg - thiotepa 15mg - antineoplastic agents
tepadina powder for solution
adienne sa - thiotepa - powder for solution - 100mg - thiotepa 100mg - antineoplastic agents
tepadina thiotepa injection powder for solution
adienne sa - thiotepa (unii: 905z5w3gkh) (thiotepa - unii:905z5w3gkh) - thiotepa 15 mg
tepadina 100 mg
mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
tepadina 15 mg
mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
tepadina 15 mg
mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.